On December 4, 2020, the House of Representatives voted 228-164 to pass a bill, the Marijuana Opportunity, Reinvestment, and Expungement Act, that decriminalizes cannabis at the federal level. Specifically, the bill removed cannabis from the Controlled Substances Act, and would require federal cannabis convictions to be expunged. The bill is not expected to gain traction in the Republican controlled Senate, as just five Republican representatives voted in favor of the bill. Nevertheless, this vote is the most significant federal action to legalize cannabis in the country’s history.
Saiber LLC is a business counseling and litigation law firm headquartered in Florham Park, with offices in Newark, New York, Philadelphia, and Scranton. For over 70 years, the firm has built a reputation for delivering innovative, creative, and cost effective solutions for a full-range of business and litigation matters. The firm represents a broad spectrum of clients, including closely-held businesses, multinational corporations, public and private universities, and government agencies. To learn more, please visit http://www.saiber.com.
As a recreational cannabis bill in the New Jersey legislature stalls, federal legislation directed at expanding the cannabis industry’s access to banking and insurance services advances in Congress. On March 28, 2019, the U.S. House of Representatives Committee on Financial Services approved H.R. 1595, the 
The issue of whether an employer is required to accommodate an employee’s alleged disability by allowing the use of medical marijuana for chronic pain and waive the requirement that he pass a drug test as a condition of employment, was recently addressed by a New Jersey federal court. In 
“We’re not going to be able, even if we desired, to take over state enforcement of routine cases that might occur,” 
